Avenue Therapeutics regains Nasdaq compliance on equity rule; remains under Panel Monitor until May 2025

AVENUE THERAPEUTICS, INC.

Notified by Nasdaq on May 21, 2024, that it meets minimum stockholders' equity requirement for continued listing.
Previously disclosed listing matter is now closed.
Subject to a Panel Monitor for one year (through May 21, 2025).
If equity rule is not satisfied during monitoring, loses compliance plan option and must request a hearing.
Company trades as ATXI on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.